Development and Evaluation of a Novel Dissolution Apparatus for Medicated Chewing Gum Products
- 79 Downloads
A novel dissolution apparatus was developed for medicated chewing gum products. A prototype gum product containing phenylpropa-nolamine hydrochloride (PPA) was used to evaluate the apparatus. The apparatus consists of a conical Teflon base and a rotating, ribbed Teflon plunger suspended in a dissolution vessel. Parameters evaluated were rotation speed, plunger frequency, medium volume, medium type, medium sampling location, number of plunger ribs, and number of gum pieces. Samples were taken over a 20-min period and samples were analyzed by HPLC. Cumulative percentage re-leased-versus-time profiles were obtained for each parameter evaluated. Statistical analysis of the gum product indicated that the only significant differences occurred at the lowest rotation speed and lowest plunger frequencies. A Level A correlation was found between the in vitro release profile for the 20-rpm and 30-cycles/min plunger frequency and the in vivo chew-out study.
Unable to display preview. Download preview PDF.
- 1.D. A. Kendall. The release of methyl salicylate flavoring from chewing gum. Flavour Ind. 5:182–183 (1974).Google Scholar
- 2.D. W. Woodford and L. J. Lesko. Relative bioavailability of aspirin gum. J. Pharm. Sci. 70:1341–1343 (1981).Google Scholar
- 3.C. J. Kleber, R. G. Schimmele, M. S. Putt, and J. C. Muhler. A mastication device designed for evaluation of chewing gums. J. Dent. Res. 60:109–114 (1981).Google Scholar
- 4.L. L. Christup and N. Moeler. Chewing gum as a drug delivery system I. In vitro simulation of human mastication and influence of formulation upon the release rate of a water soluble drug. Arch. Chem. Sci. Ed. 14:30–36 (1986).Google Scholar
- 5.L. L. Christup and M. R. Rassing. Chewing gum as a drug delivery system II. Influence of the formulation upon the rate of release of salicylamide. Farmaci Sci. Ed. 16:1–5 (1988).Google Scholar
- 6.E. F. Reynolds. Martindale, The Extra Pharmacopoeia, 29th ed., Pharmaceutical Press, London, England, 1990, p. 1475.Google Scholar
- 7.USP Subcommittee on Biopharmaceutics. In vitro-in vivo correlation for extended-release oral dosage forms. Pharm. Forum 14:4160–4161 (1988).Google Scholar